L. Yalcintepe Et Al. , "Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells," CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.47, no.7, pp.1221-1230, 2020
Yalcintepe, L. Et Al. 2020. Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.47, no.7 , 1221-1230.
Yalcintepe, L., Erdag, D., AKBAŞ, F., & Kucukkaya, B., (2020). Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.47, no.7, 1221-1230.
Yalcintepe, Leman Et Al. "Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells," CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.47, no.7, 1221-1230, 2020
Yalcintepe, Leman Y. Et Al. "Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells." CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.47, no.7, pp.1221-1230, 2020
Yalcintepe, L. Et Al. (2020) . "Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells." CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.47, no.7, pp.1221-1230.
@article{article, author={Leman YALÇINTEPE GÜNEŞTUTAR Et Al. }, title={Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells}, journal={CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY}, year=2020, pages={1221-1230} }